» Articles » PMID: 10029531

Human Cathepsin V Functional Expression, Tissue Distribution, Electrostatic Surface Potential, Enzymatic Characterization, and Chromosomal Localization

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1999 Feb 25
PMID 10029531
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Cathepsin V, a thymus and testis-specific human cysteine protease, was expressed in Pichia pastoris, and its physicokinetic properties were determined. Recombinant procathepsin V is autocatalytically activated at acidic pH and is effectively inhibited by various cysteine protease class-specific inhibitors. The S2P2 subsite specificity of cathepsin V was found to be intermediate between those of cathepsins S and L. The substrate binding pocket, S2, accepted both aromatic and nonaromatic hydrophobic residues, whereas cathepsins L and S preferred either an aromatic or nonaromatic hydrophobic residue, respectively. In contrast to cathepsin L, but similar to cathepsin S, cathepsin V exhibited only a very weak collagenolytic activity. Furthermore, cathepsin V was determined to be significantly more stable at mildly acidic and neutral pH than cathepsin L, but distinctly less stable than cathepsin S. A homology structure model of cathepsin V revealed completely different electrostatic potentials on the molecular surface when compared with human cathepsin L. The model-based electrostatic potential of human cathepsin V was neutral to weakly positive at and in the vicinity of the active site cleft, whereas that of cathepsin L was negative over extended regions of the surface. Surprisingly, the electrostatic potential of the human cathepsin V model structure resembled that of the model structure of mouse cathepsin L. These differences in the electrostatic potential at the molecular surfaces provide a reactivity determinant that may be the source of differences in substrate selectivity and pH stability. Cathepsin V was mapped to the chromosomal region 9q22.2, a site adjacent to the cathepsin L locus. The high sequence identity and the overlapping chromosomal gene loci suggest that both proteases evolved from an ancestral cathepsin L-like precursor by gene duplication.

Citing Articles

The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases.

Zhao K, Sun Y, Zhong S, Luo J Biomark Res. 2024; 12(1):165.

PMID: 39736788 PMC: 11687005. DOI: 10.1186/s40364-024-00711-9.


The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma.

He Y, Xu M, Zhou C, Dong Q, Hu Z, Ren N Int J Gen Med. 2024; 17:4867-4881.

PMID: 39465186 PMC: 11512791. DOI: 10.2147/IJGM.S467179.


Advances in Cathepsin S Inhibition: Challenges and Breakthroughs in Drug Development.

Ajani T, Magwebu Z, Chauke C, Obikeze K Pathophysiology. 2024; 31(3):471-487.

PMID: 39311309 PMC: 11417842. DOI: 10.3390/pathophysiology31030035.


The Intricate Balance between Life and Death: ROS, Cathepsins, and Their Interplay in Cell Death and Autophagy.

Voronina M, Frolova A, Kolesova E, Kuldyushev N, Parodi A, Zamyatnin Jr A Int J Mol Sci. 2024; 25(7).

PMID: 38612897 PMC: 11012956. DOI: 10.3390/ijms25074087.


An Unusual Two-Domain Thyropin from Tick Saliva: NMR Solution Structure and Highly Selective Inhibition of Cysteine Cathepsins Modulated by Glycosaminoglycans.

Matouskova Z, Orsaghova K, Srb P, Pytelkova J, Kukacka Z, Busa M Int J Mol Sci. 2024; 25(4).

PMID: 38396918 PMC: 10889554. DOI: 10.3390/ijms25042240.